Roche 4800 HPV PCR reagents and analyzer lease

Ended Awarded Last action

Contract number
36C25720N0202
Awardee
Awarding agency
Obligated
$134,552

Award facts

Contract value 100% obligated
$134,552.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Dallas, TX 75216, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 · Roche 4800 HPV PCR reagents and analyzer lease DE-obligation of option year 4 funds -$35,826
Supplemental Agreement for work within scope P00008 -$22,026
Exercise an Option P00007 $57,288
Other Administrative Action P00006 -$18,847
Exercise an Option P00005 $57,288
Supplemental Agreement for work within scope P00004 -$17,901
Exercise an Option P00003 $57,288
Supplemental Agreement for work within scope P00002 -$57,288
Exercise an Option P00001 $57,288
Original award $57,288

About this award

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, valued at $134,552.15, is for the lease of Roche 4800 HPV PCR Reagents and Analyzers. The contract does not have a set-aside designation, indicating it was awarded through open competition. Roche Diagnostics Corporation is a foreign-owned, for-profit organization that has multiple existing contract vehicles with the VA, Department of Defense, and Department of Health and Human Services, primarily for the provision of laboratory equipment, reagents, and diagnostic testing services. This delivery order contract is likely part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract or Blanket Purchase Agreement (BPA) established under the General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) and In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedules, which allow federal agencies to efficiently acquire Roche's medical diagnostic technologies through pre-negotiated pricing and terms.

Quick answers

Who was awarded contract 36C25720N0202?

36C25720N0202 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 17 (Veterans Health Administration) on February 28, 2020.

How much is contract 36C25720N0202 worth?

The government has obligated $134,552 on 36C25720N0202.

Is contract 36C25720N0202 an order under another contract?

Yes. 36C25720N0202 is a delivery order under V797D70105, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C25720N0202 competed?

The extent of competition for 36C25720N0202 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award